Sign in

CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company

CalciMedica, Inc.

Sign in to watch
Ticker
CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452120079
Phone
858-952-5500
Business address
505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
Former names
CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-29 Flynn James E 10% owner Conversion · Series C Preferred Stock −2,624,901 0
2020-09-29 Flynn James E 10% owner Conversion · Series C Preferred Stock −2,624,901 0
2020-09-29 Clarus Lifesciences III, L.P. 10% owner Conversion +1,285,327 1,285,327
2020-09-29 Clarus Lifesciences III, L.P. 10% owner Conversion +395,068 1,680,395
2020-09-29 Clarus Lifesciences III, L.P. 10% owner Purchase +250,000 $16.00 $4.0M 1,930,395
2020-09-29 Clarus Lifesciences III, L.P. 10% owner Conversion · Series B Preferred Stock −1,285,327 0
2020-09-29 Clarus Lifesciences III, L.P. 10% owner Conversion · Series C Preferred Stock −395,068 0
2020-09-29 SHAFFER CHRISTY L Director Conversion +1,586,490 1,586,490
2020-09-29 SHAFFER CHRISTY L Director Purchase +18,750 $16.00 $300K 1,605,240
2020-09-29 SHAFFER CHRISTY L Director Conversion · Series A-2 Preferred Stock −193,224 0
2020-09-29 SHAFFER CHRISTY L Director Conversion · Series B Preferred Stock −1,242,120 0
2020-09-29 SHAFFER CHRISTY L Director Conversion · Series C Preferred Stock −151,146 0
2020-09-29 ORBIMED ADVISORS LLC 10% owner Conversion +3,600,847 4,163,347
2020-09-29 ORBIMED ADVISORS LLC 10% owner Conversion · Series B Preferred Stock −2,754,273 0
2020-09-29 ORBIMED ADVISORS LLC 10% owner Conversion · Series C Preferred Stock −846,574 0
2020-09-29 Keyoung Hansoo Michael Director Conversion +1,133,596 1,133,596
2020-09-29 Keyoung Hansoo Michael Director Conversion · Series C Preferred Stock −1,133,596 0
2020-09-29 Cagle Gerald D. Director Conversion +3,322 3,322
2020-09-29 Cagle Gerald D. Director Conversion · Series B Preferred Stock −3,322 0
2020-09-25 ORBIMED ADVISORS LLC 10% owner Purchase +562,500 $16.00 $9.0M 562,500

Page 28 of 29 · 565 trades